These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6176109)

  • 1. Renal prostaglandin E2 biosynthesis: dependence on angiotensin II.
    Attallah AA; Stahl RA; Bloch DL; Ambrus JL; Lee JB
    Am J Cardiol; 1982 Apr; 49(6):1521-3. PubMed ID: 6176109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sar1-Ileu8-angiotensin on renal prostaglandin E2 biosynthesis and excretion.
    Katayama S; Attallah AA; Stahl RA; Lee JB
    J Lab Clin Med; 1987 Apr; 109(4):504-8. PubMed ID: 3546565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of angiotensin II inhibition during increases in renal venous pressure.
    Fiksen-Olsen MJ; Strick DM; Hawley H; Romero JC
    Hypertension; 1992 Feb; 19(2 Suppl):II137-41. PubMed ID: 1735568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting-enzyme inhibition and 1-sarcosine-8-isoleucine-angiotensin II: effects on renal function in the dehydrated sheep.
    Yesberg NE; Henderson M; Dallemagne C; Law S; Hamilton D; Cross RB
    Q J Exp Physiol; 1984 Jan; 69(1):133-43. PubMed ID: 6371881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposed effects of prostaglandin E2 on perfusion of rat renal cortex and medulla: interactions with the renin-angiotensin system.
    Badzynska B; Sadowski J
    Exp Physiol; 2008 Dec; 93(12):1292-302. PubMed ID: 18586855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of angiotensin I converting enzyme inhibitor (SQ 20881) on the release of prostaglandins by rabbit kidney, in vivo.
    Johns EJ; Murdock R; Singer B
    Br J Pharmacol; 1977 Aug; 60(4):573-81. PubMed ID: 198054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol stimulates rat renopapillary prostaglandin E2 (PGE2), but not PGF2 alpha biosynthesis.
    Katayama S; Lee JB
    Endocrinology; 1985 Aug; 117(2):656-61. PubMed ID: 3893988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sar1-Ile8-angiotensin II decreases urinary PGE2 and PGF2alpha excretion in rabbits on dietary sodium restriction.
    Stahl RA; Attallah AA
    Eur J Pharmacol; 1980 Jul; 65(1):81-4. PubMed ID: 7398779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
    Fujimura A; Ebihara A
    Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and prostaglandins.
    Swartz SL; Williams GH
    Am J Cardiol; 1982 Apr; 49(6):1405-9. PubMed ID: 6280473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.
    Grant TL; McGrath JC
    Br J Pharmacol; 1988 Dec; 95(4):1220-8. PubMed ID: 3146400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibitor YS980 on prostaglandin synthesis in rabbit kidney medulla slices.
    Fujimoto Y; Wada K; Kaneko M; Fujita T
    Br J Pharmacol; 1987 Nov; 92(3):479-81. PubMed ID: 3480765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin and angiotensin converting enzyme inhibition: effect on blood pressure, renin activity and renal function in hemorrhaged conscious rabbits.
    Golub MS; Berger ME; Sambhi MP; Eggena P
    Clin Exp Hypertens (1978); 1981; 3(3):477-95. PubMed ID: 6265167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction.
    Katayama S; Lee JB
    Hypertension; 1985; 7(4):554-61. PubMed ID: 3891614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.